Why the study?
Does synthetic alpha-human atrial natriuretic polypeptide (alpha-hANP) improve natriuretic and hypotensive responses in spontaneously hypertensive rats compared to normotensive rats?
Does synthetic alpha-human atrial natriuretic polypeptide (alpha-hANP) improve natriuretic and hypotensive responses in spontaneously hypertensive rats compared to normotensive rats?
Alpha-hANP produces a significantly greater natriuretic response in spontaneously hypertensive rats compared to normotensive rats, suggesting a role in water-electrolyte balance and blood pressure control.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ANP in hypertension models; human translation untested and should not change practice.
Natriuretic and hypotensive effects of synthetic alpha-human atrial natriuretic polypeptide (alpha-hANP) were investigated in anesthetized spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). The renal excretory and hypotensive effects of alpha-hANP were strengthened in a dose-dependent manner in both strains of rat. The natriuretic response to three doses of alpha-hANP (0.3, 1.0 and 3.0 micrograms/kg) were significantly greater in SHR than in WKY. These results suggest that atrial natriuretic polypeptide may play some role in water-electrolyte balance and control of blood pressure in SHR.
No takes yet. Share an insight, caveat, or question.
Kondo et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: